01:38 PM EST, 12/19/2024 (MT Newswires) -- Soho House ( SHCO ) shares surged past 55% amid heavy trading after the company said Thursday it received a $9 per share acquisition offer from a consortium supported earlier this week.

More than 6.01 million shares traded intraday compared with a daily average of over 105,000.

Omeros ( OMER ) said its pivotal trial of narsoplimab in hematopoietic stem cell transplant-associated thrombotic microangiopathy met its primary endpoint in overall survival.

Shares soared 42% as intraday trading volume soared to roughly 5.15 million from a daily average of about 773,000.

Mesoblast (MESO) said the US Food and Drug Administration approved its mesenchymal stromal cell therapy Ryoncil for steroid-refractory acute graft versus host disease in children two months and older, adolescents, and teenagers.

Shares jumped 35%, with intraday trading volume at over 3.26 million compared with a daily average of roughly 229,000.

Price: 7.62, Change: +2.71, Percent Change: +55.19